Protalix BioTherapeutics (PLX) Convertible Debt (2013 - 2023)
Protalix BioTherapeutics (PLX) posted Convertible Debt of $20.42 million for Q4 2023, down 27.6% from $28.19 million a year earlier.
Analysis
Protalix BioTherapeutics (PLX) Convertible Debt (2013 - 2023) Analysis & Trends
Since Q3 2013, Protalix BioTherapeutics has reported Convertible Debt for 33 quarters.
- Annual Convertible Debt shows a five-year compound annual growth rate of -15.7% (FY2018 to FY2023).
- In prior years, Protalix BioTherapeutics' Convertible Debt was $28.19 million in FY2022 (+1.1%), $27.89 million in FY2021 and $50.96 million in FY2019 (+6.2%).
- Quarterly Convertible Debt has run from a low of $20.13 million in Q2 2023 to a high of $53.51 million in Q3 2020 over five years.
- On a year-over-year basis, Convertible Debt increased in three of the last five quarters, with an average decline of 10.5%.
- The strongest year-over-year quarter for Convertible Debt in the past five years was Q3 2020, with growth of 6.7%; the weakest was Q3 2021, with a decline of 48.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Protalix BioTherapeutics | 207.16 Mn | 55.78 Mn | 12.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 20.42 Mn |
| Jun 30, 2023 | 20.13 Mn |
| Mar 31, 2023 | 28.27 Mn |
| Dec 31, 2022 | 28.19 Mn |
| Sep 30, 2022 | 28.11 Mn |
| Jun 30, 2022 | 28.03 Mn |
| Mar 31, 2022 | 27.96 Mn |
| Dec 31, 2021 | 27.89 Mn |
| Sep 30, 2021 | 27.82 Mn |
| Sep 30, 2020 | 53.51 Mn |
| Jun 30, 2020 | 52.62 Mn |
| Mar 31, 2020 | 51.78 Mn |
| Dec 31, 2019 | 50.96 Mn |
| Sep 30, 2019 | 50.16 Mn |
| Jun 30, 2019 | 49.40 Mn |
| Mar 31, 2019 | 48.67 Mn |
| Dec 31, 2018 | 47.97 Mn |
| Sep 30, 2018 | 47.32 Mn |
| Jun 30, 2018 | 46.74 Mn |
| Mar 31, 2018 | 46.11 Mn |
API Access
Protalix BioTherapeutics Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=PLX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();